CPSC recall 20724
NumbSkin pain relief cream with lidocaine
- CPSC
- unknown
- Published 2020-03-18
On 2020-03-18 the CPSC announced a recall of NumbSkin pain relief cream with lidocaine by Seenext Venture, citing the packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children….
| Agency | CPSC |
|---|---|
| Recall number | 20724 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2020-03-18 |
| Published | 2020-03-18 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Seenext Venture |
| Distribution | US |
Product
NumbSkin pain relief cream with lidocaine | This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.
Reason
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.